6.82
                                            
            Aquestive Therapeutics Inc stock is traded at $6.82, with a volume of 1.74M.
            It is up +2.40% in the last 24 hours and up +22.00% over the past month.
            Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
        
        See More
    Previous Close:
              $6.66
            Open:
              $6.68
            24h Volume:
                1.74M
            Relative Volume:
              0.63
            Market Cap:
                $680.12M
            Revenue:
              $58.36M
            Net Income/Loss:
              $-25.72M
            P/E Ratio:
              -18.73
            EPS:
                -0.3641
            Net Cash Flow:
                $-24.91M
            1W Performance:
              -0.29%
            1M Performance:
              +22.00%
            6M Performance:
                +133.16%
            1Y Performance:
              +24.23%
            Aquestive Therapeutics Inc Stock (AQST) Company Profile
Name
                  
                      Aquestive Therapeutics Inc
                    
                Sector
                  Phone
                  
                      908-941-1900
                    
                Address
                  
                      30 TECHNOLOGY DRIVE, WARREN, NJ
                    
                Compare AQST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS | 
|---|---|---|---|---|---|---|
|   
                          
                                AQST
                            
                             Aquestive Therapeutics Inc | 6.82 | 805.68M | 58.36M | -25.72M | -24.91M | -0.3641 | 
|   
                          
                                ZTS
                            
                             Zoetis Inc | 144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 | 
|   
                          
                                TAK
                            
                             Takeda Pharmaceutical Co Adr | 13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 | 
|   
                          
                                HLN
                            
                             Haleon Plc Adr | 9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 | 
|   
                          
                                TEVA
                            
                             Teva Pharmaceutical Industries Ltd Adr | 20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 | 
|   
                          
                                UTHR
                            
                             United Therapeutics Corp | 445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 | 
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change | 
|---|---|---|---|
| Jun-02-25 | Resumed | Oppenheimer | Outperform | 
| Dec-17-24 | Initiated | Cantor Fitzgerald | Overweight | 
| May-10-24 | Initiated | Leerink Partners | Outperform | 
| Apr-11-24 | Initiated | Piper Sandler | Overweight | 
| Mar-28-24 | Initiated | Raymond James | Outperform | 
| Apr-07-21 | Resumed | RBC Capital Mkts | Outperform | 
| Apr-22-19 | Initiated | H.C. Wainwright | Buy | 
| Jan-03-19 | Initiated | Lake Street | Buy | 
| Aug-20-18 | Initiated | JMP Securities | Mkt Outperform | 
| Aug-20-18 | Initiated | RBC Capital Mkts | Outperform | 
                    View All
                     
                  
                Aquestive Therapeutics Inc Stock (AQST) Latest News
Can Aquestive's Oral, Non-Device Epinephrine Film Capture A Share Of The Growing U.S. Market? - RTTNews
Will Aquestive Therapeutics Inc. bounce back from current supportWeekly Profit Recap & Consistent Growth Equity Picks - newser.com
Detecting support and resistance levels for Aquestive Therapeutics Inc.Weekly Trade Review & Weekly Watchlist for Hot Stocks - newser.com
Why Aquestive Therapeutics Inc. stock could outperform in 2025July 2025 Catalysts & Daily Risk Controlled Trade Plans - newser.com
Real time alert setup for Aquestive Therapeutics Inc. performanceJuly 2025 Short Interest & AI Driven Stock Reports - newser.com
Volatility clustering patterns for Aquestive Therapeutics Inc.Share Buyback & High Accuracy Trade Alerts - newser.com
Will Aquestive Therapeutics Inc. stock gain from strong economyJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
Can technical indicators confirm Aquestive Therapeutics Inc.’s reversalChart Signals & Stepwise Swing Trade Plans - newser.com
Long term hold vs stop loss in Aquestive Therapeutics Inc.Quarterly Profit Review & Detailed Earnings Play Alerts - newser.com
Why Aquestive Therapeutics Inc. stock is trending among retail tradersProduct Launch & Low Risk Investment Opportunities - newser.com
Risk vs reward if holding onto Aquestive Therapeutics Inc.2025 Volatility Report & Smart Money Movement Alerts - newser.com
Aquestive Therapeutics to Attend 2025 ACAAI Annual Meeting - The Manila Times
Aquestive Therapeutics Inc. stock chart pattern explainedMarket Risk Report & Real-Time Market Trend Scan - newser.com
Using AI based signals to follow Aquestive Therapeutics Inc.2025 Winners & Losers & Weekly Consistent Profit Watchlists - newser.com
What Wall Street predicts for Aquestive Therapeutics Inc. stock priceGDP Growth & Safe Entry Trade Reports - newser.com
Top chart patterns to watch in Aquestive Therapeutics Inc.July 2025 Macro Moves & Low Risk High Win Rate Stock Picks - newser.com
Is Aquestive Therapeutics Inc. stock attractive for retirement portfoliosWeekly Trade Summary & Accurate Entry and Exit Point Alerts - newser.com
Will Aquestive Therapeutics Inc. stock benefit from AI adoptionCPI Data & Safe Swing Trade Setup Alerts - Fundação Cultural do Pará
Can trapped investors hope for a rebound in Aquestive Therapeutics Inc.Dividend Hike & High Accuracy Investment Signals - newser.com
Why Aquestive Therapeutics Inc. stock attracts high net worth investors - Fundação Cultural do Pará
Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET - The Manila Times
Aquestive Therapeutics to Report Third Quarter 2025 - GlobeNewswire
Aquestive Therapeutics (AQST) to Release Quarterly Earnings on Monday - MarketBeat
Aquestive Therapeutics Inc Stock (AQST) Financials Data
Revenue
Net Income
Cash Flow
EPS
Aquestive Therapeutics Inc Stock (AQST) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | 
|---|---|---|---|---|---|---|---|
| Jung Cassie | Chief Operating Officer | Oct 15 '25 | Sale | 7.01 | 67,575 | 473,701 | 240,771 | 
| Kraus Carl N | Chief Medical Officer | Oct 15 '25 | Sale | 7.00 | 20,272 | 141,904 | 282,475 | 
| Boyd Peter E. | See Remarks | Oct 15 '25 | Sale | 7.00 | 10,000 | 70,000 | 268,323 | 
        Open in Yahoo
        |
        Open in Google
            |
            Open in Finviz
        |
        Open in MarketWatch
            |
            Open in EDGAR    
        |
        Open in Reuters
    
    
                Cap:
                 
                  | 
                Volume (24h):
                 
            
         
                     
                             Get the Stockscreener App
                    Get the Stockscreener App